Nifty

:

23907.25

Sensex

:

79117.11

557.35 (2.39%)
1961.32 (2.54%)

Login

Nifty
Sensex

:
:

23907.25
79117.11

557.35 (2.39%)
1961.32 (2.54%)

Medicamen Biotech Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 531146 | NSE: MEDICAMEQ

Watchlist

NSE BSE

502.65

05-Jul-2024

Open
High
Low
Previous Close

510.00
512.25
498.05
513.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

21470
108.46
649.00
355.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

568.66
81.65
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

582.41
0.22%
2.72

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.28
7.40
15.81

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.38
3.85
-0.48

PAT CAGR (%)

10 Years
5 Years
3 Years

40.62
-6.51
-13.96

P:E (Median)

8 Years
5 Years
3 Years

57.37
57.37
58.85

P:BV (Average)

8 Years
5 Years
3 Years

4.98
4.98
4.97

EV:EBITDA (Average)

8 Years
5 Years
3 Years

33.57
33.57
34.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 42.84 42.67 0.40% 41.48 40.50 2.42% 45.01 37.15 21.16% 44.20 34.12 29.54%
Expenses 36.30 36.52 -0.60% 36.62 33.09 10.67% 38.19 30.38 25.71% 38.62 28.25 36.71%
EBITDA 6.55 6.15 6.50% 4.86 7.41 -34.41% 6.82 6.77 0.74% 5.58 5.87 -4.94%
EBIDTM 15.29% 14.42% 11.72% 18.30% 15.16% 18.22% 12.63% 17.19%
Other Income 0.29 0.55 -47.27% 0.57 0.38 50.00% 0.54 0.35 54.29% 0.83 0.63 31.75%
Interest 1.01 0.91 10.99% 0.68 0.96 -29.17% 1.87 0.86 117.44% 0.65 0.68 -4.41%
Depreciation 2.57 1.80 42.78% 1.74 1.68 3.57% 1.77 1.61 9.94% 1.76 1.60 10.00%
PBT 3.25 4.00 -18.75% 3.01 5.15 -41.55% 3.73 4.65 -19.78% 4.01 4.21 -4.75%
Tax 0.99 0.99 0.00% 0.76 0.74 2.70% 0.62 0.60 3.33% 1.24 0.45 175.56%
PAT 2.27 3.01 -24.58% 2.26 4.42 -48.87% 3.10 4.05 -23.46% 2.77 3.76 -26.33%
PATM 5.30% 7.06% 5.44% 10.91% 6.89% 10.89% 6.26% 11.02%
EPS 1.79 2.37 -24.47% 1.78 3.48 -48.85% 2.44 3.19 -23.51% 2.18 2.96 -26.35%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 44.74 43.54 2.76% 43.05 41.94 2.65% 47.32 38.66 22.40% 46.50 35.58 30.69%
Expenses 39.43 38.90 1.36% 39.60 34.99 13.18% 41.57 32.17 29.22% 41.61 29.71 40.05%
EBITDA 5.32 4.65 14.41% 3.45 6.95 -50.36% 5.75 6.49 -11.40% 4.89 5.88 -16.84%
EBIDTM 11.88% 10.67% 8.00% 16.57% 12.16% 16.79% 10.52% 16.51%
Other Income 0.29 0.55 -47.27% 0.59 0.38 55.26% 0.57 0.35 62.86% 0.83 0.63 31.75%
Interest 1.04 0.91 14.29% 0.71 0.96 -26.04% 1.89 0.86 119.77% 0.65 0.68 -4.41%
Depreciation 2.61 1.82 43.41% 1.77 1.69 4.73% 1.77 1.62 9.26% 1.81 1.60 13.12%
PBT 1.96 2.46 -20.33% 1.56 4.68 -66.67% 2.66 4.36 -38.99% 3.27 4.22 -22.51%
Tax 1.05 0.99 6.06% 0.76 0.74 2.70% 0.62 0.59 5.08% 1.24 0.45 175.56%
PAT 0.91 1.48 -38.51% 0.80 3.95 -79.75% 2.04 3.77 -45.89% 2.03 3.77 -46.15%
PATM 2.02% 3.39% 1.85% 9.41% 4.32% 9.75% 4.37% 10.60%
EPS 1.15 1.17 -1.71% 1.06 3.30 -67.88% 1.67 3.07 -45.60% 1.60 2.98 -46.31%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 173.53 172.39 137.88 115.45 110.15 117.34 122.60 111.51 82.46 67.28 77.79 Net Sales Growth 12.36% 25.03% 19.43% 4.81% -6.13% -4.29% 9.95% 35.23% 22.56% -13.51% Cost Of Goods Sold 95.72 71.96 52.66 43.51 47.48 59.66 69.26 49.05 37.50 29.05 37.26 Gross Profit 77.81 100.43 85.22 71.93 62.67 57.69 53.34 62.46 44.96 38.23 40.53 GP Margin 44.84% 58.26% 61.81% 62.30% 56.90% 49.16% 43.51% 56.01% 54.52% 56.82% 52.10% Total Expenditure 149.73 145.15 113.27 91.35 90.12 99.22 105.14 94.73 70.87 61.75 72.75 Power & Fuel Cost - 7.12 5.67 5.86 2.68 2.90 2.11 2.78 2.35 2.76 3.29 % Of Sales - 4.13% 4.11% 5.08% 2.43% 2.47% 1.72% 2.49% 2.85% 4.10% 4.23% Employee Cost - 22.12 18.57 14.50 8.79 9.29 8.09 9.05 6.65 4.86 5.42 % Of Sales - 12.83% 13.47% 12.56% 7.98% 7.92% 6.60% 8.12% 8.06% 7.22% 6.97% Manufacturing Exp. - 29.32 27.11 18.12 26.48 21.99 19.85 26.99 16.76 17.05 17.69 % Of Sales - 17.01% 19.66% 15.70% 24.04% 18.74% 16.19% 24.20% 20.33% 25.34% 22.74% General & Admin Exp. - 6.90 5.19 4.92 2.63 3.61 3.29 3.74 4.77 3.56 3.68 % Of Sales - 4.00% 3.76% 4.26% 2.39% 3.08% 2.68% 3.35% 5.78% 5.29% 4.73% Selling & Distn. Exp. - 6.48 2.92 3.36 1.71 1.45 2.33 3.11 2.84 3.92 4.46 % Of Sales - 3.76% 2.12% 2.91% 1.55% 1.24% 1.90% 2.79% 3.44% 5.83% 5.73% Miscellaneous Exp. - 1.25 1.16 1.07 0.34 0.32 0.22 0.01 0.01 0.55 4.46 % Of Sales - 0.73% 0.84% 0.93% 0.31% 0.27% 0.18% 0.01% 0.01% 0.82% 1.23% EBITDA 23.81 27.24 24.61 24.10 20.03 18.12 17.46 16.78 11.59 5.53 5.04 EBITDA Margin 13.72% 15.80% 17.85% 20.87% 18.18% 15.44% 14.24% 15.05% 14.06% 8.22% 6.48% Other Income 2.23 2.31 2.46 1.72 0.75 1.91 3.66 1.89 0.31 0.70 1.10 Interest 4.21 5.65 3.39 1.94 1.51 0.93 1.38 2.71 3.61 3.62 3.92 Depreciation 7.84 7.01 6.35 5.77 2.52 2.50 2.21 2.06 1.92 1.90 2.10 PBT 14.00 16.89 17.33 18.10 16.75 16.60 17.52 13.90 6.36 0.71 0.12 Tax 3.61 3.59 2.33 3.20 4.26 4.34 5.50 3.79 1.20 0.23 -0.32 Tax Rate 25.79% 21.26% 13.44% 17.68% 25.43% 26.14% 31.39% 27.27% 18.87% 32.39% -266.67% PAT 10.40 13.30 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 0.44 PAT before Minority Interest 10.40 13.30 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 0.44 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.99% 7.72% 10.88% 12.91% 11.34% 10.45% 9.81% 9.07% 6.26% 0.71% 0.57% PAT Growth -31.76% -11.33% 0.60% 19.38% 1.88% 1.91% 18.99% 95.93% 975.00% 9.09% EPS 8.19 10.47 11.81 11.74 9.83 9.65 9.47 7.96 4.06 0.38 0.35

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 181.61 179.31 140.87 115.45 112.72 125.50 122.60 Net Sales Growth 13.71% 27.29% 22.02% 2.42% -10.18% 2.37% Cost Of Goods Sold 97.11 73.18 53.25 43.51 50.06 65.62 69.26 Gross Profit 84.50 106.13 87.62 71.93 62.65 59.89 53.34 GP Margin 46.53% 59.19% 62.20% 62.30% 55.58% 47.72% 43.51% Total Expenditure 162.21 155.79 116.53 91.36 93.04 106.03 105.14 Power & Fuel Cost - 7.14 5.67 5.86 2.68 2.90 2.11 % Of Sales - 3.98% 4.02% 5.08% 2.38% 2.31% 1.72% Employee Cost - 29.07 20.15 14.50 9.00 9.52 8.09 % Of Sales - 16.21% 14.30% 12.56% 7.98% 7.59% 6.60% Manufacturing Exp. - 29.33 27.14 18.12 26.48 21.99 19.85 % Of Sales - 16.36% 19.27% 15.70% 23.49% 17.52% 16.19% General & Admin Exp. - 8.58 5.67 4.93 2.76 3.92 3.29 % Of Sales - 4.79% 4.02% 4.27% 2.45% 3.12% 2.68% Selling & Distn. Exp. - 7.27 3.48 3.36 1.71 1.77 2.33 % Of Sales - 4.05% 2.47% 2.91% 1.52% 1.41% 1.90% Miscellaneous Exp. - 1.23 1.18 1.07 0.34 0.32 0.22 % Of Sales - 0.69% 0.84% 0.93% 0.30% 0.25% 0.18% EBITDA 19.41 23.52 24.34 24.09 19.68 19.47 17.46 EBITDA Margin 10.69% 13.12% 17.28% 20.87% 17.46% 15.51% 14.24% Other Income 2.28 2.33 2.46 1.72 0.75 1.94 3.66 Interest 4.29 5.67 3.39 1.94 1.51 0.93 1.38 Depreciation 7.96 7.09 6.37 5.77 2.52 2.50 2.21 PBT 9.45 13.08 17.05 18.09 16.39 17.98 17.52 Tax 3.67 3.58 2.32 3.20 4.26 4.69 5.50 Tax Rate 38.84% 27.37% 13.61% 17.69% 25.99% 26.08% 31.39% PAT 5.78 9.49 14.73 14.90 12.13 13.29 12.03 PAT before Minority Interest 6.97 9.49 14.73 14.90 12.13 13.29 12.03 Minority Interest 1.19 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.18% 5.29% 10.46% 12.91% 10.76% 10.59% 9.81% PAT Growth -55.44% -35.57% -1.14% 22.84% -8.73% 10.47% EPS 4.55 7.47 11.60 11.73 9.55 10.46 9.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 209.21 193.80 148.04 134.35 122.48 86.63 74.61 26.78 17.91 17.18 Share Capital 12.71 12.65 12.22 12.22 12.22 11.70 11.70 10.52 9.99 9.51 Total Reserves 196.49 180.02 135.82 122.14 110.26 74.93 62.91 15.49 7.92 7.39 Non-Current Liabilities 0.21 0.66 6.04 7.84 3.58 1.42 1.73 3.95 4.87 6.74 Secured Loans 0.95 0.87 5.07 6.40 2.36 0.02 0.14 2.46 3.52 4.59 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.76 1.66 1.46 1.16 1.06 0.98 1.18 0.85 0.61 1.49 Current Liabilities 82.30 80.46 71.13 50.27 50.40 48.54 41.21 42.67 37.24 44.74 Trade Payables 37.97 45.51 41.74 29.58 31.96 30.57 21.80 22.31 18.76 26.52 Other Current Liabilities 10.70 7.21 5.03 4.99 5.59 0.78 0.87 4.81 3.20 2.54 Short Term Borrowings 28.64 23.31 19.27 10.93 7.62 11.61 14.24 14.09 14.76 15.56 Short Term Provisions 4.99 4.43 5.09 4.78 5.23 5.58 4.30 1.46 0.53 0.12 Total Liabilities 291.72 274.92 225.21 192.46 176.46 136.59 117.55 73.40 60.02 68.66 Net Block 91.10 92.36 92.48 89.64 33.69 24.38 25.34 19.05 19.10 19.84 Gross Block 135.86 130.12 124.26 115.66 57.74 46.58 45.78 37.66 35.79 34.94 Accumulated Depreciation 44.75 37.76 31.78 26.02 24.05 22.20 20.45 18.61 16.69 15.10 Non Current Assets 132.73 109.98 96.48 93.37 77.17 40.01 26.46 20.02 19.42 20.15 Capital Work in Progress 0.00 0.00 0.00 0.00 40.50 14.76 0.28 0.45 0.00 0.00 Non Current Investment 7.76 4.08 2.06 2.06 2.06 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.20 1.09 0.87 0.78 0.63 0.58 0.57 0.52 0.32 0.32 Other Non Current Assets 32.67 12.46 1.08 0.90 0.29 0.29 0.28 0.00 0.00 0.00 Current Assets 152.37 157.97 120.98 92.43 97.24 96.17 90.99 53.38 40.60 48.51 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.07 0.02 0.02 Inventories 59.33 45.06 27.01 5.20 16.96 15.26 14.23 13.79 11.14 13.46 Sundry Debtors 48.29 60.23 61.18 49.75 43.93 43.37 38.42 25.69 16.09 26.51 Cash & Bank 14.62 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 Other Current Assets 30.14 2.58 20.28 22.95 34.12 29.01 15.60 10.87 10.63 6.21 Short Term Loans & Adv. 27.80 29.66 8.69 11.44 12.60 14.41 1.50 9.01 8.45 4.40 Net Current Assets 70.07 77.51 49.85 42.16 46.85 47.62 49.78 10.71 3.35 3.77 Total Assets 291.72 274.91 225.20 192.46 176.45 136.60 117.55 73.40 60.02 68.66

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 206.98 193.41 146.47 132.89 121.22 86.63 Share Capital 12.71 12.65 12.22 12.22 12.22 11.70 Total Reserves 194.27 178.16 134.25 120.67 109.00 74.93 Non-Current Liabilities 0.50 0.65 6.04 7.84 3.58 1.42 Secured Loans 1.26 0.87 5.07 6.40 2.36 0.02 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.76 1.66 1.46 1.16 1.06 0.98 Current Liabilities 84.56 82.57 72.69 53.27 56.48 48.54 Trade Payables 38.95 47.59 43.30 32.21 37.38 30.57 Other Current Liabilities 11.06 7.28 5.03 4.90 5.91 0.78 Short Term Borrowings 29.56 23.31 19.27 10.93 7.62 11.61 Short Term Provisions 4.99 4.39 5.09 5.23 5.57 5.58 Total Liabilities 292.04 276.63 225.20 194.00 181.28 136.59 Net Block 91.85 92.66 92.48 89.64 33.69 24.38 Gross Block 136.70 130.43 124.26 115.66 57.74 46.58 Accumulated Depreciation 44.85 37.77 31.78 26.02 24.05 22.20 Non Current Assets 125.74 106.22 94.42 91.31 75.11 40.01 Capital Work in Progress 0.00 0.00 0.00 0.00 40.50 14.76 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.22 1.11 0.87 0.78 0.63 0.58 Other Non Current Assets 32.67 12.46 1.08 0.90 0.29 0.29 Current Assets 159.59 163.36 123.04 96.03 104.13 96.17 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 59.38 45.06 27.01 5.20 16.96 15.26 Sundry Debtors 55.26 65.26 63.22 52.55 49.96 43.37 Cash & Bank 14.79 20.78 3.82 3.89 3.09 8.52 Other Current Assets 30.18 2.58 20.28 22.95 34.12 29.01 Short Term Loans & Adv. 27.84 29.69 8.69 11.44 12.60 14.41 Net Current Assets 75.04 80.79 50.35 42.76 47.65 47.62 Total Assets 292.03 276.64 225.20 194.00 181.28 136.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -0.25 -3.50 4.81 12.98 11.71 4.30 -5.45 3.59 6.21 -3.27 PBT 16.89 17.33 18.10 16.75 16.60 17.35 13.90 6.36 0.48 0.44 Adjustment 10.67 8.56 7.04 3.43 2.81 2.24 4.28 4.88 5.12 4.38 Changes in Working Capital -24.74 -32.52 -17.13 -2.74 -3.35 -11.29 -23.14 -7.65 0.61 -8.09 Cash after chg. in Working capital 2.82 -6.62 8.01 17.44 16.06 8.30 -4.95 3.59 6.21 -3.27 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.06 3.12 -3.20 -4.46 -4.35 -4.00 -0.50 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -8.71 -7.54 -8.47 -17.81 -39.35 -14.76 -7.99 -2.30 -1.05 0.12 Net Fixed Assets -5.74 -5.86 -8.60 -17.42 -36.90 -15.28 -7.95 -2.32 -0.85 -0.07 Net Investments -3.68 -2.02 0.00 0.00 -2.06 0.07 0.00 -0.05 0.00 0.00 Others 0.71 0.34 0.13 -0.39 -0.39 0.45 -0.04 0.07 -0.20 0.19 Cash from Financing Activity 3.14 27.67 4.39 5.68 21.36 -3.69 33.14 -1.04 -4.73 2.74 Net Cash Inflow / Outflow -5.82 16.63 0.73 0.85 -6.29 -14.15 19.70 0.25 0.42 -0.42 Opening Cash & Equivalents 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 2.71 Closing Cash & Equivalent 14.62 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity -6.74 -6.29 4.11 12.77 12.80 4.30 PBT 13.08 17.05 18.09 16.39 17.98 17.35 Adjustment 10.77 8.56 7.04 3.43 2.81 2.24 Changes in Working Capital -27.52 -28.78 -17.82 -2.59 -3.64 -11.29 Cash after chg. in Working capital -3.68 -3.17 7.31 17.23 17.15 8.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.06 -3.12 -3.20 -4.46 -4.35 -4.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.56 -5.88 -8.47 -17.81 -37.29 -14.76 Net Fixed Assets -5.74 -5.86 -8.60 -17.42 -36.90 Net Investments -3.68 -2.02 0.00 0.00 -2.06 Others 3.86 2.00 0.13 -0.39 1.67 Cash from Financing Activity 6.31 29.13 4.30 5.84 19.06 -3.69 Net Cash Inflow / Outflow -5.99 16.95 -0.07 0.80 -5.43 -14.15 Opening Cash & Equivalents 20.78 3.82 3.89 3.09 8.52 22.66 Closing Cash & Equivalent 14.79 20.78 3.82 3.89 3.09 8.52

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 159.34 146.79 114.84 104.52 98.58 73.69 63.68 24.73 17.92 17.77 ROA 4.69% 6.00% 7.14% 6.77% 7.83% 9.46% 10.59% 7.74% 0.75% 0.66% ROE 6.85% 9.20% 11.12% 10.06% 11.86% 14.96% 20.12% 23.50% 2.76% 2.66% ROCE 10.13% 10.95% 12.82% 13.12% 15.26% 20.22% 24.91% 24.10% 11.36% 11.58% Fixed Asset Turnover 1.30 1.08 0.96 1.27 2.25 2.65 2.68 2.25 1.90 2.25 Receivable days 114.88 160.69 175.37 155.22 135.78 121.75 104.83 92.47 115.48 109.77 Inventory Days 110.51 95.39 50.92 36.72 50.11 43.90 45.82 55.17 66.68 61.53 Payable days 211.72 302.36 299.07 236.52 114.92 91.29 86.27 110.47 140.55 129.01 Cash Conversion Cycle 13.66 -46.28 -72.78 -44.58 70.96 74.36 64.38 37.17 41.61 42.30 Total Debt/Equity 0.15 0.14 0.18 0.15 0.10 0.14 0.19 0.68 1.14 1.23 Interest Cover 3.99 6.11 10.33 12.08 18.83 13.68 6.13 2.76 1.20 1.03

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 157.52 145.25 113.56 103.33 97.55 73.69 ROA 3.34% 5.87% 7.11% 6.46% 8.36% 8.80% ROE 4.94% 9.13% 11.25% 9.89% 12.94% 13.95% ROCE 8.46% 10.85% 12.94% 12.99% 16.54% 19.30% Fixed Asset Turnover 1.34 1.11 0.96 1.30 2.41 2.63 Receivable days 122.66 166.45 183.01 165.97 135.71 129.12 Inventory Days 106.29 93.37 50.92 35.88 46.85 45.43 Payable days 215.82 311.49 316.67 253.69 117.21 106.58 Cash Conversion Cycle 13.14 -51.67 -82.73 -51.84 65.35 67.97 Total Debt/Equity 0.16 0.14 0.19 0.15 0.10 0.14 Interest Cover 3.31 6.03 10.32 11.85 20.30 13.68

Top Investors:

pharmadanica a/s

ginnerup capital aps

investor education and protection fund (iepf)

Annual Reports:

News Update:

Medicamen Biotech’s Bhiwadi Formulation facility gets final EU GMP Certification
11th Sep 2024, 17:36 PM

The company has received the final approval from the Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, GREECE
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback